Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Feb 12, 2026 · Filed Feb 17, 2026
Globus Medical's GC, Corporate Secretary sold $877K of Globus Medical shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$876,700
Shares × reported transaction price
36 days after results of Jan 7, 2026, 12 days before results of Feb 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.7% | +1.0% | +5.7% |
| 30 days | −4.3% | −5.5% | +1.2% |
| 90 days | −11.3% | +6.9% | −18.3% |
| 180 days | −5.6% | +12.6% | −18.2% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$1.89M of Globus Medical
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.